The following list of published studies, which are part of the Performance Improvement-Coalition of Rheumatology Educators (CORE™) Stage B, are provided here for you by CORE™ and this activity’s faculty in order that you may share these with the related healthcare providers in your office and/or clinic for their reference and education.

Attitudes to Early Rheumatoid Arthritis; Changing Patterns. Results of a Survey
Authors: D. Aletaha, G. Eberl, V.P.K. Nell, K.P. Machold, J.S. Smolen
Citation: Ann Rheum Dis. 2004;63:1269-1275.doi: 10.1136/ard/2003.015131


Value of Disease Activity Score 28 (DAS28) and DAS28-3 Compared to American College of Rheumatology-Defined Remission in Rheumatoid Arthritis
Authors: A. Balsa, L. Carmona, I. Gonzalez-Alvaro, M.A. Belmonte, Z. Tena, R. Sanmarti, for the EMECAR study Group
Citation: J Rheumatol. 2004;31:40-46.


Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the BeSt Study)
Authors: Y.P.M. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, C.F. Allaart, D. van Zeben, P.J.S.M. Kerstens, J.M.W. Hazes, A.H. Zwinderman, H.K. Ronday, K.H. Han, M.L. Westedt, A.H. Gerards, J.H.L.M van Groenendael, W.F. Lems, M.V. van Krugten, F.C. Breedveld, and B.A.C. Dijkmans
Citation: Arthritis Rheum. 2005;52(11)3381-3390. Doi: 10.1002/art.21405


Treatment of Rheumatoid Arthritis
Author: P. Emery
Citation: BMJ. 2006;332(21)152-155.


Effect of a Treatment Strategy of Tight Control for Rheumatoid Arthritis (the TICORA study): A Single-Blind Randomized Controlled Trial
Authors: C. Grigor, H. Capell, A. Stirling, A.D. McMahon, P. Lock, R. Vallance, W. Kincaid, D. Porter
Citation: Lancet. 2004;364:263-269.


New Drugs for Rheumatoid Arthritis
Authors: N.J. Olsen, C. Michael Stein
Citation: N Engl J Med. 2004;350:2167-2179.


Dose Escalation of the Anti-TNF-x Agents in Patients with Rheumatoid Arthritis. A Systematic Review
Authors: R. Ariza-Ariza, F. Nacarro-Sarabia, B. Hernandez-Cruz, L. Rodriquez-Arboleya, V. Navarro-Compan, J. Toyos
Citation: Rheumatology. 2007;46:529-532.


Most Visits of Most Patients with Rheumatoid Arthritis to Most Rheumatologists Do Not include a Formal Quantitative Joint Count
Authors: T. Pincus, O.G. Segurado
Citation: Ann Rheum Dis. 2006;65:820-822. doi:10.1136/ard..2005.044230


Anti-CCP Antibody Test Predicts the Disease Course during 3 Years in Early Rheumatoid Arthritis (the Swedish TIRA project)
Authors: A. Kastbom, G. Strandberg, A. Lindroos, T. Skogh
Citation: Ann Rheum Dis. 2004;63:1085-1089. doi:1136-ard.2003.016808


Is the Outcome of Rheumatoid Arthritis Changed With the Use of New Disease-Modifying Antirheumatic Drugs?
Author: J. Kremer
Citation: Arthritis Rheum. 2005;53(5):636-638. Doi: 10.1002/art.21447


Predictive Markers in Rapidly Progressing Rheumatoid Arthritis
Author: R. Landewe
Citation: J Rheumatol. 2007;34(Suppl 80):8-15.


RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories
Authors: T. Pincus, C. Swearingen, M. Bergman, Y. Yazici
Citation: J. Rheumatol. 2008;35:2136-2147. doi:10.3899-jrheum.080182


Predictors of Productivity Loss in Early Rheumatoid Arthritis: a 5 Year Follow Up Study
Authors: K. Puolakka, H. Kautiainen, T. Mottonen, P. Hannonen, M. Hakala, M. Korpela, K. Ilva, U. Yli-Kerttula, H. Piirainen, M. Leirisalo-Repo, for the FIN-RACo Trial Group
Citation: Ann Rheum Dis. 2005;64:130-133. doi:10.1136/ard.2003.019034


Cigarette Smoking and Radiographic Progression in Rheumatoid Arthritis
Authors: A. Finckh, S. Dehler, K.H. Costenbader, C. Gabay, on behalf of the Swiss Clinical Quality Management project for Ra (SCQM)
Citation: Ann Rheum Dis. 2007:66:1066-1071. doi: 10.1136-ard.2006.065060


Interaction Between Smoking, the Shared Epitope, and Anti-Cyclic Citrullinated Peptide: A Mixed Picture in Three Large North American Rheumatoid Arthritis Cohorts
Authors: H. Lee, P. Irigoyen, M. Kern, A. Lee, F. Batliwalla, H. Khalili, F. Wolfe, R.F. Lum, Elena Massarotti, Michael Weisman, Claire Bombardier, Elizabeth W. Karlson, Lindsey A. Criswell, R. Vlietinck, P.K. Gregersen
Citation: Arthritis Rheum. 2007;56(6):1745-1753. doi: 10.1002/art.22703


Erythrocyte Sedimentation Rate and C-reactive Protein Levels Are Poorly Correlated with Clinical Measures of Disease Activity in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Osteoarthritis Patients
Authors: R.T. Keenan, C.J. Swearingen, Y. Yazici
Citation: Clin Exp Rheumatol. 2008;26:814-819.


Click here for a PDF of the Multi-Dimensional Health Assessment Questionnaire

Click on titles below to participate in complimentary CME-accredited webcasts

Disease Activity Measures and Outcomes in Rheumatoid Arthritis Randomized Clinical Trials versus “Routine Care”

Quantitative Measures in RA: Joint Counts, Radiographs, Laboratory Tests, Patient Questionnaires to Improve Outcomes, Document Care, and Raise Quality-Part 1

MDHAQ and Rapid3 in Usual Clinical Care-Part 2